RIVA-IRBESARTAN
LABORATOIRE RIVA INC.
Quick answers
Is there a shortage of RIVA-IRBESARTAN in Canada?
No. There is no current shortage of RIVA-IRBESARTAN 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AVA-IRBESARTAN
AVANSTRA INC
Other Products
AVAPRO
SANOFI-AVENTIS CANADA INC
VAN-IRBESARTAN
VANC PHARMACEUTICALS INC
RIVA-IRBESARTAN
LABORATOIRE RIVA INC.
PRO-IRBESARTAN
PRO DOC LIMITEE
DOM-IRBESARTAN
DOMINION PHARMACAL
DIN
02524759
Strength
300MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from LABORATOIRE RIVA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
160MG · DIN 02017431
80MG · DIN 02017458
DIN 02154234
500MG · DIN 02362201
325MG · DIN 02362198
500MG · DIN 02362228
325MG · DIN 02022214
500MG · DIN 02022222
15MG · DIN 02009889
30MG · DIN 02009757
10000UNIT · DIN 00821772
DIN 02245592